UBS Group
ALHC icon

UBS Group’s Alignment Healthcare ALHC Stock Holding History

UBS Group’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Buy
1,420,219
+1,270,705
+850% +$24.4M ﹤0.01% 2132
2026
Q1 		$2.63M Sell
149,514
-254,518
-63% -$5.11M ﹤0.01% 4713
2025
Q4 		$7.98M Buy
404,032
+119,105
+42% +$2.14M ﹤0.01% 3539
2025
Q3 		$4.97M Sell
284,927
-539,944
-65% -$8.01M ﹤0.01% 4040
2025
Q2 		$11.5M Buy
824,871
+341,039
+70% +$5.49M ﹤0.01% 2930
2025
Q1 		$9.01M Buy
483,832
+248,384
+105% +$3.7M ﹤0.01% 3141
2024
Q4 		$2.65M Buy
235,448
+160,268
+213% +$1.87M ﹤0.01% 4446
2024
Q3 		$889K Buy
75,180
+25,663
+52% +$243K ﹤0.01% 4759
2024
Q2 		$387K Sell
49,517
-37,685
-43% -$246K ﹤0.01% 5194
2024
Q1 		$433K Buy
87,202
+85,031
+3,917% +$544K ﹤0.01% 5318
2023
Q4 		$18.7K Buy
2,171
+2,111
+3,518% +$15.4K ﹤0.01% 7150
2023
Q3 		$416 Sell
60
-69,530
-100% -$419K ﹤0.01% 8510
2023
Q2 		$400K Buy
69,590
+36,615
+111% +$237K ﹤0.01% 5013
2023
Q1 		$210K Sell
32,975
-25,129
-43% -$240K ﹤0.01% 5356
2022
Q4 		$683K Buy
58,104
+53,645
+1,203% +$653K ﹤0.01% 4421
2022
Q3 		$53K Buy
4,459
+3,811
+588% +$55.6K ﹤0.01% 6296
2022
Q2 		$8K Sell
648
-6,736
-91% -$71.1K ﹤0.01% 8278
2022
Q1 		$83K Sell
7,384
-21,192
-74% -$191K ﹤0.01% 6053
2021
Q4 		$401K Buy
28,576
+26,842
+1,548% +$470K ﹤0.01% 5162
2021
Q3 		$28K Buy
1,734
+1,059
+157% +$20.5K ﹤0.01% 6809
2021
Q2 		$16K Buy
675
+365
+118% +$8.88K ﹤0.01% 7559
2021
Q1 		$7K Buy
+310
New +$6.06K ﹤0.01% 8138

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's ALHC Position: Q2 2026 in Review

UBS Group increased its Alignment Healthcare (ALHC) stake by 850% in Q2 2026, buying an estimated $24.4M and bringing the position to 1,420,219 shares worth $33.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

UBS Group first reported a position in ALHC in Q1 2021 and has held it in 22 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • UBS Group held 1,420,219 shares of Alignment Healthcare worth $33.8M as of Q2 2026.
  • UBS Group bought 1,270,705 Alignment Healthcare shares in Q2 2026, an estimated $24.4M.
  • Alignment Healthcare made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2132 holding.
  • UBS Group first reported a position in Alignment Healthcare in Q1 2021 and has held it in 22 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.